CEMEX, S.A.B. de C.V. (NYSE:CX) Given Consensus Recommendation of "Hold" by Brokerages

Shares of CEMEX, S.A.B. de C.V. (NYSE:CX - Get Free Report) have received a consensus rating of "Hold" from the seven research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $7.58.

CX has been the topic of several research analyst reports. JPMorgan Chase & Co. raised their price objective on CEMEX from $6.00 to $6.80 and gave the stock a "neutral" rating in a research note on Tuesday, April 29th. Bradesco Corretora set a $7.50 price objective on CEMEX and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. The Goldman Sachs Group raised their price objective on CEMEX from $8.00 to $9.00 and gave the stock a "buy" rating in a research note on Thursday, February 27th. Royal Bank of Canada raised their price objective on CEMEX from $5.00 to $5.25 and gave the stock an "underperform" rating in a research note on Tuesday, April 29th. Finally, Morgan Stanley cut CEMEX from an "overweight" rating to an "equal weight" rating in a research note on Wednesday, March 26th.

CEMEX Stock Down 0.4%

Shares of CEMEX stock traded down $0.03 on Thursday, hitting $6.82. 11,558,375 shares of the company's stock traded hands, compared to its average volume of 11,713,000. The stock has a market cap of $9.88 billion, a P/E ratio of 10.83 and a beta of 1.41. The company has a quick ratio of 0.58, a current ratio of 0.82 and a debt-to-equity ratio of 0.43. The firm's 50-day moving average is $6.07 and its 200 day moving average is $5.96. CEMEX has a 52-week low of $4.89 and a 52-week high of $7.37.

CEMEX (NYSE:CX - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The construction company reported $0.08 earnings per share (EPS) for the quarter. CEMEX had a return on equity of 7.78% and a net margin of 5.70%. The firm had revenue of $186.46 million for the quarter, compared to analysts' expectations of $214.59 million. Equities analysts anticipate that CEMEX will post 0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of CX. Blue Trust Inc. increased its holdings in shares of CEMEX by 17.2% during the fourth quarter. Blue Trust Inc. now owns 50,636 shares of the construction company's stock valued at $309,000 after purchasing an additional 7,423 shares during the period. Hantz Financial Services Inc. increased its holdings in shares of CEMEX by 28.2% during the fourth quarter. Hantz Financial Services Inc. now owns 246,623 shares of the construction company's stock valued at $1,391,000 after purchasing an additional 54,231 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of CEMEX by 41.3% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 30,080 shares of the construction company's stock valued at $170,000 after purchasing an additional 8,795 shares during the period. Choreo LLC acquired a new position in shares of CEMEX during the fourth quarter valued at $268,000. Finally, Activest Wealth Management acquired a new position in shares of CEMEX during the fourth quarter valued at $113,000. 82.97% of the stock is owned by institutional investors and hedge funds.

CEMEX Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.